2964
TESTOSTERONE
GEL FOR LOSS OF LIBIDO
Gabe Mirkin, M.D.
A study from Australia in the medical journal, Menopause, shows that Androgel, a gel containing
the male hormone, testosterone, improves well-being, mood, and sexual function in premenopausal women with low libido and
low testosterone. As women age, many lose interest in making love and feel insecure, even though their blood levels of the
male hormones testosterone and DHEAS are normal or low. The bodies of all heathy women produce more of the male hormone, testosterone,
than the female hormone, estrogen. Just like men, with aging women have a significant lowering of their blood testosterone
levels, and this lowering of testosterone can cause depression and loss of muscle strength and sexual desire. Healthy women
in their 40's have approximately half the testosterone level as women in their 20's.
A group of reproductive endocrinologists classified the symptoms of depression and loss of libido
and muscle strength into one syndrome which they called Female Androgen Insufficiency Syndrome. This syndrome is most common
at the menopause and in women who have had their ovaries removed, but it can occur any time in a woman's life. The commonly-prescribed
treatment of estrogen replacement to postmenopausal women and those who have had their ovaries removed often causes and worsens
this syndrome.
The brain produces a hormone called FSH that causes the ovaries to produce the female hormone,
estrogen. Estrogen circulates in the blood and goes to the brain, where it stops the brain from producing FSH. Without FSH,
the ovaries stop making the male hormone, testosterone. Many studies show that giving estrogen to menopausal women may reduce
their sex drive by lowering blood levels of testosterone. A woman's sexual desire is driven by her body's production of testosterone,
not estrogen. Women who have had their ovaries removed suffer from the same symptoms because the ovaries produce most of the
male hormones in a woman's body. So women who suffer from Androgen Deficiency Syndrome caused by taking estrogen at menopause
or by having had their ovaries removed surgically can feel much better when they take a combination of the two hormones produced
by normal ovaries: estrogen and testosterone.
The adrenal glands, located near the kidneys, also produce a male hormones, called DHEAS. Women
who have underactive adrenal glands have low blood levels of that hormone, and also suffer from Female Androgen Deficiency
Syndrome. Their symptoms can be controlled by taking DHEA supplements.
If you are a woman who has even one of the following symptoms, ask your doctor to test you for
lack of male hormones: depression, lack of motivation, loss of energy, lack of interest in making love, lack of joy in making
love, muscle weakness, osteoporosis or weak bones, or vaginal pain during intercourse. Ask your doctor to draw blood tests
for testosterone, the male hormone produced by the ovaries, and DHEAS, the male hormone produced by the adrenal glands. Even
if your blood levels of the male hormones are normal, you could still try the testosterone cream, Androgel. Too much of the
cream can cause masculinizing symptoms, but as long as you do not exceed 2.5 grams of Androgel each week, you are at low risk
for growing hair on your face and body.
1) Transdermal testosterone therapy improves well-being, mood,
and sexual function in premenopausal women. Menopause - the Journal of the North American Menopause Society, 2003, Vol 10,
Iss 5, pp 390-398. R Goldstat, E Briganti, J Tran, R Wolfe, SR Davis. Davis SR, Jean Hailes Fdn, Res Unit, 173 Carinish Rd,
Clayton, Vic 3168, AUSTRALIA.
1a) Androgen production in women. Fertility and Sterility, 2002, Vol 77, Iss 4, Suppl.
4, pp S3-S5. HG Burger.
2)Aromatization of androgens in women: current concepts and findings. Fertility and Sterility,
2002, Vol 77, Iss 4, Suppl. 4, pp S6-S10. ER Simpson.
3)Role of androgens in female genital sexual arousal: receptor
expression, structure, and function. Fertility and Sterility, 2002, Vol 77, Iss 4, Suppl. 4, pp S11-S18. AM Traish, N Kim,
K Min, R Munarriz, I Goldstein.
4) Dehydroepiandrosterone: a springboard hormone for female sexuality. Fertility and
Sterility, 2002, Vol 77, Iss 4, Suppl. 4, pp S19-S25. RF Spark.
5) Hormones, mood, sexuality, and the menopausal transition.
Fertility and Sterility, 2002, Vol 77, Iss 4, Suppl. 4, pp S42-S48. L Dennerstein, J Randolph, J Taffe, E Dudley, H Burger.
6)
Randomized clinical trials of combined estrogen-androgen preparations: effects on sexual functioning. Fertility and Sterility,
2002, Vol 77, Iss 4, Suppl. 4, pp S49-S54. BB Sherwin. 7) Sexual effects of androgens in women: some theoretical considerations.
Fertility and Sterility, 2002, Vol 77, Iss 4, Suppl. 4, pp S55-S59. J Bancroft. 8) Androgen deficiency in the oophorectomized
woman. Fertility and Sterility, 2002, Vol 77, Iss 4, Suppl. 4, pp S60-S62. JL Shifren. 9) Androgen deficiency: menopause and
estrogen-related factors. Fertility and Sterility, 2002, Vol 77, Iss 4, Suppl. 4, pp S63-S67. PM Sarrel.
10) When
to suspect androgen deficiency other than at menopause. Fertility and Sterility, 2002, Vol 77, Iss 4, Suppl. 4, pp S68-S71.
SR Davis.
11) The hypoandrogenic woman: pathophysiologic overview. Fertility and Sterility, 2002, Vol 77, Iss 4, Suppl.
4, pp S72-S76. GA Bachmann.
12) Estrogen replacement therapy: effects on the endogenous androgen milieu. Fertility
and Sterility, 2002, Vol 77, Iss 4, Suppl. 4, pp. S77-S82. JA Simon.
13) Female androgen insufficiency: the Princeton
consensus statement on definition, classification, and assessment. Fertility and Sterility, 2002, Vol 77, Iss 4, pp 660-665.
G Bachmann, J Bancroft, G Braunstein, H Burger, S Davis, L Dennerstein, I Goldstein, A Guay, S Leiblum, R Lobo, M Notelovitz,
R Rosen, P Sarrel, B Sherwin, J Simon, E Simpson, J Shifren, R Spark, A Traish.
At drmirkin.com
2292 -- 9/1/03
POSTMENOPAUSAL
TESTOSTERONE INCREASES SEXUALITY
Gabe Mirkin, M.D.
A study from Columbia Medical School shows that many postmenopausal women who take estrogen replacement
have reduced sexual interest and desire, and giving these women the male hormone, testosterone, significantly increases their
interest and desire.
Masculinizing hormones are far more effective than feminizing hormones in increasing a woman's
interest and desire in lovemaking. The brains of normal women produce hormones called FSH and LH that stimulate the ovaries
to produce both male and female hormones. When male and female hormones rise too high, they prevent the brain from producing
the hormones that stimulate the ovaries. So giving postmenopausal women the female hormone, estrogen, can stop their brains
from making FSH which stimulates the ovaries to make masculinizing hormones. Giving these women both estrogen and testosterone
pills markedly elevated their blood levels of masculinizing hormones, and increased their interest in making love.
0.625 mg of esterified estrogens and 1.25 mg of methyltestosterone
testosterone and suppressed SHBG. Scores measuring sexual interest or desire and frequency of desire increased from baseline
with combination treatment and were significantly greater than those achieved with esterified estrogens alone. Title Comparative
effects of oral esterified estrogens with and without methyllestosterone on endocrine profiles and dimensions of sexual function
in postmenopausal women with hypoactive sexual desire. Fertility and Sterility, 2003, Vol 79, Iss 6, pp 1341-1352. RA Lobo,
RC Rosen, HM Yang, B Block, RG VanderHoop. Lobo RA, Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, 622 W 168th
St, New York,NY 10032 USA
1237 -- 9/3/02
FEMALE
SEXUAL DYSFUNCTION
Gabe Mirkin, M.D.
According to several research papers, more than 90 percent of middle-aged women suffer from decreased
desire to make love, not being aroused by sexual stimuli, or inability to climax. An article in the Mayo Clinic Proceedings
summarizes the accepted treatment plan for this condition, called Female Sexual Dysfunction.
Lack of desire is associated with poor health, overwork, lack of privacy, or failure to be in
a caring relationship. It is also associated with depression, certain medications and drugs, and low blood levels of the male
hormone, testosterone. According to the study, 87 percent of married women claim that they have decreased desire, 83 percent
find it very difficult to climax, 74 percent lubricate poorly, and 71 percent have discomfort on making love.
Every woman who feels that she has Female Sexual Dysfunction should realize that hundreds of
different medications can prevent a woman from having desire or being able to climax: antihistamines, blood pressure medications,
antibiotics, cancer drugs, stomach and intestinal medications, contraceptives, sleeping pills, antidepressants, alcohol, recreational
drugs, and all the antiestrogens such as tamoxifen and Lupron. It is very common for women to lose interest in making love
after they have had their ovaries removed because a woman's ovaries continue to produce large amounts of male hormones for
her entire life. Many women who have had their ovaries removed require testosterone to increase their sexual desire.
Many products on the market today are sold to increase sexual desire; they often have some variation
of Viagra in their names. Many products claim that they contain yohimbine that increases sexual desire. Several studies show
that yohimbine is not more effective than a placebo, so nobody should waste money buying products that claim that they contain
yohimbine to improve sexual desire or performance.
There is no evidence whatever that Viagra increases sexual desire in women or in men. Viagra
helps a man achieve an erection by increasing blood flow to the penis. It fills a woman's pelvic organs with blood. Since
vaginal secretions come from the bloodstream, Viagra will increase vaginal secretions, even though it does not increase desire.
The common cold medicine called ephedrine also increases vaginal secretions and can be used to increase lubrication. Prescriptions
containing phentolamine can markedly increase vaginal lubrication.
The most common cause of a dry vagina after stimulation is a vaginal infection that should be
treated with the appropriate medication to kill the offending germ, whether it is herpes, chlamydia, mycoplasma, ureaplasma,
gonorrhea, the wart virus, yeast, or intestinal bacteria.
Every women who suffers from decreased sexual desire, decreased arousal or lack of orgasms should
get blood tests for testosterone and DHEAS. Testosterone is the male hormone produce by the ovaries, and DHEAS is the male
hormone produced by the adrenal glands. Testosterone can increase sexual desire, even in women who have normal or high levels
of that hormone.
The majority of women over age 50, and many under 50, cannot climax with penile-vaginal lovemaking
because the vagina is not the source of an orgasm, the clitoris is. It takes continual and prolonged stimulation of the clitoris
for most older women to achieve an orgasm. A vibrator can provide this stimulation if other techniques are not effective.
Recently, the Food and Drug Administration of the United States approved a hand-held, battery-operated,
device with a small plastic cup that applies a very gently vacuum to the clitoris. It has been shown to make the clitoris
larger temporarily by filling the clitoris with blood. It also increases vaginal secretions and improves a woman's ability
to climax.
Mayo Clin Proc July,2002.
To
receive Dr. Mirkin's